RO94455B - Process for preparing 2-oxindol-1-carboxamide derivatives - Google Patents

Process for preparing 2-oxindol-1-carboxamide derivatives

Info

Publication number
RO94455B
RO94455B RO123678A RO12367885A RO94455B RO 94455 B RO94455 B RO 94455B RO 123678 A RO123678 A RO 123678A RO 12367885 A RO12367885 A RO 12367885A RO 94455 B RO94455 B RO 94455B
Authority
RO
Romania
Prior art keywords
chlorine
phenyl
formula
trifluoromethyl
fluorine
Prior art date
Application number
RO123678A
Other languages
Romanian (ro)
Other versions
RO94455A (en
Inventor
Bernard Kadin Saul
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of RO94455A publication Critical patent/RO94455A/en
Publication of RO94455B publication Critical patent/RO94455B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Inventia se refera la un procedeu pentru prepararea unor derivati de 2-oxindol-1-carboxamida cu formula generala I (vezi formula în pag.1 a descrierii) în care X este hidrogen, clor, trifluormetil, fluor, acetil, benzoil, nitro, Y este hidrogen, fluor, clor sau X si Y împreuna formeaza o catena cu formula: 4-CH2-CH2-CH2-5,5-CH2-CH2-CH2-6,6-CH2-CH2-CH2-CH2-7,5-CH=CH-CH=CH-6,5-O-CH2-CH2-6,5-CH2-CH2-O-6,5-S-CH2-CH2-6,5-O-CH=CH-6,5-S-CH=CH-6,5-CH=CH-S-6, numerele laterale indicînd pozitiile de legatura la nucleul de 2-oxindol, R1 reprezinta furil, tienil, tienilmetil, benzil, benzil substituit cu clor sau fluor, fenoximetil, piridil, metil, biciclo [2,2,1] heptan-2-il, ciclohexil, trifluormetil, fenil, ciclopropil, izopropil, ciclobutil, ciclopentil, fenil substituit cu fluor sau clor, feniletil, R2 reprezinta n-butil, t-butil, etil, izopropil, ciclohexil, benzil, fenil sau fenil mono sau disubstituit cu fluor, clor, trifluormetil si metil, care consta în aceea ca un 2-oxindol cu formula generala II (vezi formula în pag.1 a descrierii) reactioneaza cu un compus de forma R1COOH.The invention relates to a process for the preparation of 2-oxindole-1-carboxamide derivatives of the general formula I (see formula on page 1 of the description) wherein X is hydrogen, chlorine, trifluoromethyl, fluoro, acetyl, benzoyl, Y is hydrogen, fluorine, chlorine or X and Y together form a chain of the formula: 4-CH 2 -CH 2 -CH 2 -5,5 -CH 2 -CH 2 -CH 2 -6,6 -CH 2 -CH 2 -CH 2 -CH 2 -7, 5-CH = CH-CH = CH-6,5-O-CH2-CH2-CH2-CH2-6,5-6,5-O-CH2-6,5-S-CH2-O-CH = CH- 6-CH-CH = CH-6,5-CH = CH-S-6, the side numbers indicating the linkage positions of the 2-oxindole ring, R 1 represents furyl, thienyl, thienylmethyl, benzyl, benzyl substituted with chlorine or fluorine, phenoxymethyl, pyridyl, methyl, bicyclo [2.2.1] heptan-2-yl, cyclohexyl, trifluoromethyl, phenyl, cyclopropyl, isopropyl, cyclobutyl, cyclopentyl, phenyl substituted with fluoro or chloro, phenylethyl, R2 represents n- , t-butyl, ethyl, isopropyl, cyclohexyl, benzyl, phenyl or phenyl which is mono- or disubstituted by fluorine, chlorine, trifluoromethyl and methyl, which comprises reacting a 2-oxindole General Formula II (see formula on page 1 of the description) is reacted with a compound of the formula R 1 COOH.

RO123678A 1984-05-04 1985-05-03 Process for preparing 2-oxindol-1-carboxamide derivatives RO94455B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
RO94455A RO94455A (en) 1988-06-30
RO94455B true RO94455B (en) 1988-07-01

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
RO118604A RO91141B (en) 1984-05-04 1985-05-03 Process for the preparation of 2-oxindol-1-carboxamide derivatives
RO123678A RO94455B (en) 1984-05-04 1985-05-03 Process for preparing 2-oxindol-1-carboxamide derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RO118604A RO91141B (en) 1984-05-04 1985-05-03 Process for the preparation of 2-oxindol-1-carboxamide derivatives

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO91141B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
DD232916A5 (en) 1986-02-12
IN161509B (en) 1987-12-19
MX5839A (en) 1993-11-01
HU196057B (en) 1988-09-28
EG17193A (en) 1990-08-30
NO163132B (en) 1990-01-02
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
SU1468413A3 (en) 1989-03-23
YU44998B (en) 1991-06-30
AR241159A2 (en) 1991-12-30
MA20424A1 (en) 1985-12-31
CS320285A2 (en) 1987-03-12
NO851774L (en) 1985-11-05
YU73085A (en) 1988-04-30
CS252828B2 (en) 1987-10-15
PL253203A1 (en) 1986-06-17
RO91141A (en) 1987-06-30
BG60208B2 (en) 1993-12-30
MW1685A1 (en) 1986-09-10
RU2017729C1 (en) 1994-08-15
ES8609248A1 (en) 1986-07-16
JPS60243068A (en) 1985-12-03
FI80016C (en) 1990-04-10
PT80375A (en) 1985-05-01
AR241159A1 (en) 1991-12-30
KR870000497B1 (en) 1987-03-12
PL145416B1 (en) 1988-09-30
IE851103L (en) 1985-11-04
ES8707182A1 (en) 1987-07-16
KR850008154A (en) 1985-12-13
FI80016B (en) 1989-12-29
RO94455A (en) 1988-06-30
ZW7885A1 (en) 1985-07-24
ES542813A0 (en) 1986-07-16
ES551275A0 (en) 1987-07-16
PT80375B (en) 1987-09-30
PL257892A1 (en) 1986-10-07
ZA853324B (en) 1986-12-30
OA08098A (en) 1987-03-31
BG60207B2 (en) 1993-12-30
FI851756L (en) 1985-11-05
RO91141B (en) 1987-07-03
NO163132C (en) 1990-04-11
HUT37754A (en) 1986-02-28
FI851756A0 (en) 1985-05-03

Similar Documents

Publication Publication Date Title
IL95975A0 (en) Benzimidazole derivatives,their production and use
DE3270307D1 (en) Succinimide derivates and process for preparation thereof
RO90952B (en) PROCESS FOR PREPARATION OF 2-OXINDOL DERIVATIVES
TR200003332T2 (en) Method to produce isoxazolin-3-yl-acyl benzene
MX9704646A (en) 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents.
NO914558D0 (en) PREPARATION AND USE OF CONDENSED HETEROCYCLIC COMPOUND
FR2364198A1 (en) NEW PRODUCTS WITH HERBICIDAL ACTION, PHENOXYVALERIC ACID DERIVATIVES
RO70771B (en) Process for the preparation of aminoacylated heterocyclic compounds
AU628521B2 (en) Improvements in or relating to organic compounds
NZ225072A (en) Preparation of substituted indolinone derivatives and intermediates therefor
MY104850A (en) N-phenyloyrazole derivatives
RO94455B (en) Process for preparing 2-oxindol-1-carboxamide derivatives
RO92320B (en) PROCEDURE FOR PREPARING ACTIVE OPTICAL CARNITINTINYL CLARITY
SE8501679L (en) STEREO-CONTROLLED ACETOXIAZETIDINON PROCEDURE
DE3852008D1 (en) Links.
AU3491489A (en) Substituted-1-amino-2-cyano-3-phenyl-4-nitro-but-1-ene- derivatives as intermediates in herbicidal manufacture
ES465927A1 (en) A PROCEDURE FOR THE PRODUCTION OF TRICYCLE COMPOUNDS
GB1498931A (en) Tetrahalopentyl ketone derivatives processes for producing them and their conversion to beta-dihaloethenylcyclopropane derivatives
FR2354326A1 (en) NEW 3- (ALKYL OXYGENE) -1,9-DIHYDROXY (OR 1-HYDROXY-9-CETO) -DIBENZO (B, D) PYRANS WITH ANALGESIC ACTIVITY
ES8301931A1 (en) Imidazoles.
ES8608488A1 (en) Substituted 1-aminoalkylamino-4-aryloxypiperidines, a process for their preparation, intermediates thereof, and their use as medicaments.
ES8202800A1 (en) Derivatives of 4-methyl-5-(2-aminoethyl)-thiomethyl-imidazole having therapeutic activity.
IL56507A (en) (trihalomethyl)dimethyloxabicyclohexanone derivatives for the preparation of cis dihalovinyldimethylcyclopropanecarboxylic acids
RO81210B (en) Process for preparing some 1, 2, 4-oxadiazine derivatives
ES8204995A1 (en) 4,4-Disubstituted spiro-1,4-dihydropyridines, process for producing them and their use as intermediates.